These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7312354)
1. [Adjuvant therapy of pemphigus with plasmapheresis]. Török L; Borka I; Reszler M; Tóth E Orv Hetil; 1981 Sep; 122(38):2349-51. PubMed ID: 7312354 [No Abstract] [Full Text] [Related]
4. [Plasma exchange therapy in pemphigus vulgaris and bullous pemphigoid--our clinical experiences and the role of bullous pemphigoid antibody in blister formation]. Watanabe S Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):953-64. PubMed ID: 6363766 [No Abstract] [Full Text] [Related]
5. [New etiopathogenic and therapeutic findings in bullous skin diseases]. Rozsívalová V; Jelínková R; Salavec M; Chýlková V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1986; 29(4-5):497-512. PubMed ID: 3326155 [No Abstract] [Full Text] [Related]
6. [Plasma exchange therapy]. Klemm-Mayer H Z Hautkr; 1984 Nov; 59(21):1423-5. PubMed ID: 6516508 [No Abstract] [Full Text] [Related]
7. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264 [TBL] [Abstract][Full Text] [Related]
8. [Plasmapheresis in the treatment of bullous skin diseases]. Neumann E; Skalisz H; Bowszyc J Przegl Dermatol; 1980; 67(4):487-92. PubMed ID: 7001548 [No Abstract] [Full Text] [Related]
14. Clinical and laboratory evaluation of hemocarboadsorption in autoimmune bullous dermatoses. Grando SA; Drannik GN; Glukhenky BT; Kostromin AP; Romanenko AB; Chayun OA; Chernyavski AI Int J Artif Organs; 1990 Mar; 13(3):181-8. PubMed ID: 2189836 [TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis as a supplementary treatment in pemphigus. Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH Arch Immunol Ther Exp (Warsz); 1981; 29(6):763-7. PubMed ID: 7349095 [TBL] [Abstract][Full Text] [Related]
16. [Significance of raised production of eicosanoids during the increase of immunosuppressive activity of the serum after hemosorption]. Grando SA; Drannik GN Biull Eksp Biol Med; 1990 Feb; 109(2):172-4. PubMed ID: 2186817 [No Abstract] [Full Text] [Related]
18. Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016. Schmidt E; Spindler V; Eming R; Amagai M; Antonicelli F; Baines JF; Belheouane M; Bernard P; Borradori L; Caproni M; Di Zenzo G; Grando S; Harman K; Jonkman MF; Koga H; Ludwig RJ; Kowalczyk AP; Müller EJ; Nishie W; Pas H; Payne AS; Sadik CD; Seppänen A; Setterfield J; Shimizu H; Sinha AA; Sprecher E; Sticherling M; Ujiie H; Zillikens D; Hertl M; Waschke J J Invest Dermatol; 2017 Jun; 137(6):1199-1203. PubMed ID: 28390814 [TBL] [Abstract][Full Text] [Related]
19. [Corticoids and plasma exchange in autoimmune bullous dermatoses]. Roujeau JC; Marchesseau P; André C; Touzet C Ann Med Interne (Paris); 1986; 137 Suppl():11-4. PubMed ID: 3545005 [No Abstract] [Full Text] [Related]
20. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid. Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]